IEFM
ARNA

IQ EQ Fund Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

IQ EQ Fund Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-59,663
Closed -$5.54M – 233
2021
Q4 		$5.54M Buy
59,663
+6,249
+12% +$412K 0.85% 35
2021
Q3 		$3.18M Sell
53,414
-28,185
-35% -$1.66M 0.49% 71
2021
Q2 		$5.57M Buy
81,599
+20,433
+33% +$1.33M 0.85% 30
2021
Q1 		$4.24M Buy
61,166
+46,503
+317% +$3.58M 0.75% 32
2020
Q4 		$1.13M Buy
14,663
+8,252
+129% +$619K 0.26% 113
2020
Q3 		$479K Buy
6,411
+2,208
+53% +$147K 0.14% 132
2020
Q2 		$265K Buy
+4,203
New +$231K 0.09% 164

IQ EQ Fund Management's ARNA Position: Q1 2022 in Review

IQ EQ Fund Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 59,663 shares — an estimated $5.54M sold.

IQ EQ Fund Management first reported a position in ARNA in Q2 2020 and held it in 7 quarters. The position peaked at $5.57M in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • IQ EQ Fund Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • IQ EQ Fund Management sold 59,663 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.54M.
  • IQ EQ Fund Management first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 7 quarters.
  • IQ EQ Fund Management's Arena Pharmaceuticals Inc position peaked at $5.57M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on IQ EQ Fund Management's 13F filing for Q1 2022, filed 28 Apr 2022.